Company news
Pacira BioSciences, Inc. news in 2020
Pacira BioSciences, Inc.'s news releases, calls and decks from 2020, newest first.
Pacira BioSciences Reports Preliminary Net Product Sales of $38.9 Million for November 2020
December 8, 2020
Pacira Receives European Commission Approval for EXPAREL® (bupivacaine liposome injectable suspension) for the Treatment of Postsurgical Pain
November 17, 2020
Pacira BioSciences Reports Preliminary Net Product Sales of $41.7 Million for October 2020
November 10, 2020
Pacira BioSciences Reports Third Quarter 2020 Financial Results and Business Update
October 28, 2020
Pacira Launches State-of-the-Art Training Center Dedicated to Advancing Best Practice Regional Approaches to Manage Acute Pain
October 20, 2020
Pacira to Report Third Quarter 2020 Financial Results on Thursday October 29, 2020
October 19, 2020
Pacira BioSciences Reports Preliminary Net Product Sales of $116.9 Million for the Third Quarter of 2020
October 6, 2020
Pacira Receives Positive CHMP Opinion for EXPAREL® (bupivacaine liposome injectable suspension) for the Treatment of Postsurgical Pain
September 17, 2020
Pacira BioSciences Reports Preliminary Net Product Sales of $36.9 Million for August 2020
September 8, 2020
Pacira BioSciences Reports Second Quarter 2020 Financial Results and Business Update
August 5, 2020
Pacira Announces Publication of Phase 4 Study of EXPAREL in Cesarean Section Procedures in Anesthesia & Analgesia
August 4, 2020
Pacira BioSciences Announces FDA Acceptance of sNDA for EXPAREL Use in Pediatric Patients
August 3, 2020
Pacira to Report Second Quarter 2020 Financial Results on Thursday August 6, 2020
July 29, 2020
Pacira BioSciences Announces Settlement of Government Investigation
July 27, 2020
Pacira BioSciences, Inc. Announces Pricing of $350.0 Million Aggregate Principal Amount of 0.750% Convertible Senior Notes due 2025
July 6, 2020
Pacira BioSciences, Inc. Announces Proposed Offering of $300.0 Million Aggregate Principal Amount of Convertible Senior Notes
July 5, 2020
Pacira BioSciences Announces Conclusion of EXPAREL Agreement with DePuy Synthes
July 1, 2020
Pacira BioSciences Reports First Quarter 2020 Financial Results and Business Update
May 6, 2020
Pacira BioSciences Appoints Donald C. Manning, M.D., Ph.D. as Chief Medical Officer
May 3, 2020
Pacira to Report First Quarter 2020 Financial Results on Thursday May 7, 2020
April 29, 2020
Pacira Reports Record Fourth Quarter and Full-Year Revenues
February 19, 2020
Pacira to Report 2019 Financial Results on Thursday February 20, 2020
February 12, 2020
Pacira BioSciences Launches National Regional Anesthesia Training Initiative with Envision Physician Services
January 20, 2020
Pacira BioSciences Reports Full-Year 2019 Preliminary Revenue of $421.0 Million
January 8, 2020
EXPAREL Achieves Primary and Key Secondary Endpoints in Phase 4 CHOICE Study in Cesarean Section Patients
January 6, 2020